Ross RK - Search Results

1

Genetic susceptibility to cancer from exogenous and endogenous exposures.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. Among authors: ross rk. J Cell Biochem Suppl. 1996;25:15-22. doi: 10.1002/(sici)1097-4644(1996)25+<15::aid-jcb2>3.0.co;2-5. J Cell Biochem Suppl. 1996. PMID: 9027593 Review.

2

Evidence of an X-linked or recessive genetic component to prostate cancer risk.

Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Monroe KR, et al. Among authors: ross rk. Nat Med. 1995 Aug;1(8):827-9. doi: 10.1038/nm0895-827. Nat Med. 1995. PMID: 7585188

3

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Reichardt JK, et al. Among authors: ross rk. Cancer Res. 1995 Sep 15;55(18):3973-5. Cancer Res. 1995. PMID: 7664265

4

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Ingles SA, et al. Among authors: ross rk. J Natl Cancer Inst. 1997 Jan 15;89(2):166-70. doi: 10.1093/jnci/89.2.166. J Natl Cancer Inst. 1997. PMID: 8998186

5

A polymorphism in the CYP17 gene increases the risk of breast cancer.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. Feigelson HS, et al. Among authors: ross rk. Cancer Res. 1997 Mar 15;57(6):1063-5. Cancer Res. 1997. PMID: 9067272

6

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk.

Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Devgan SA, et al. Among authors: ross rk. Prostate. 1997 Sep 15;33(1):9-12. doi: 10.1002/(sici)1097-0045(19970915)33:1<9::aid-pros2>3.0.co;2-h. Prostate. 1997. PMID: 9294620

7

Sex steroid hormones and genetic susceptibility to breast and prostate cancer.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. Among authors: ross rk. Drug Metab Rev. 1998 May;30(2):421-34. doi: 10.3109/03602539808996320. Drug Metab Rev. 1998. PMID: 9606611 Review. No abstract available.

8

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Ross RK, et al. Cancer Res. 1998 Oct 15;58(20):4497-504. Cancer Res. 1998. PMID: 9788589 Review.

9

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Coetzee GA, Pearce CL, Reichardt JK, Bretsky P, Kolonel LN, Henderson BE, Lander E, Altshuler D, Daley G. Ross RK, et al. Eur Urol. 1999;35(5-6):355-61. doi: 10.1159/000019909. Eur Urol. 1999. PMID: 10325489 Review.

10

Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci.

Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Xue W, et al. Among authors: ross rk. Cancer Res. 2000 Feb 15;60(4):839-41. Cancer Res. 2000. PMID: 10706090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters